{"version":"1.0","type":"link","title":"Predictive value analysis of CEA, CA125 and CYFRA21-1 levels in evaluating the efficacy of tislelizumab combined with gemcitabine-cisplatin chemotherapy in patients with advanced non-small cell lung cancer.","author_name":"Wang L 외","author_url":"https://prs-insight.online/author/Wang%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97777","thumbnail_width":1200,"thumbnail_height":630}